Andreas Kogelnik: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) |
Notjusttired (talk | contribs) m (Undo revision 110726 by Notjusttired (talk)) |
(One intermediate revision by the same user not shown) | |
(No difference)
|
Revision as of 22:37, May 11, 2022
Andreas ("Andy") M. Kogelnik, MD, PhD, is an internal medicine and infectious diseases specialist and the director of the Open Medicine Institute, Mountain View, California, US.[1] His interests are in bioinformatics and genomic medicine and is committed to the study and treatment of ME/CFS and other chronic illnesses.[1]
Education[edit | edit source]
- MD from Emory University[1]
- PhD in bioengineering from Georgia Tech[1]
- Residency in internal medicine at Stanford University[1]
- Fellowship in infectious diseases at Stanford University[1]
ME/CFS Common Data Element (CDE) Project[edit | edit source]
Kogelnik is a member of the Immune Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project, sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[2]
Research publications on ME/CFS[edit | edit source]
- 2006, Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue[3] - (Abstract)
- 2011, No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected[4] - (Full text)
- 2013, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Valganciclovir in a Subset of Patients With Chronic Fatigue Syndrome[5] - (Full text)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[6] - (Full text)
Articles[edit | edit source]
Talks and interviews[edit | edit source]
- May 2011 - Keynote Speaker at the 6th Invest in ME International ME Conference - Speech Title: Strategies for ME Research and Collaboration[7]
- 2012, ME/CFS Alert Episode 23:
- The Open Medicine Institute, Part 1,
- The Open Medicine Institute, Part 2,
- The Open Medicine Institute, Part 3
- 2012, ME/CFS Alert Episode 22:
- 2012, 7th Invest in ME International ME Conference - Strategies for ME Research and Collaboration[8]
- 2013, 8th Invest in ME International ME Conference Keynote Speaker: Strategies for ME Research and Collaboration[9]
- 2014, YouTube - What Works For Chronic Fatigue Syndrome
- 2014, 9th Invest in ME International ME Conference 2014 - No title of talk given
- 2014, ME/CFS Alert Episode 56: Dr. Andreas Kogelnik on the "Real Thrust" of ME/CFS Research
- 2014, ME/CFS Alert Episode 55: Interview with Dr. Andreas Kogelnik
- 17 Feb 2014, Dr. Andreas Kogelnik and Llewellyn King on Sirius XM Radio POTUS Channel 124
- 23 Jan 2014, “The Jim Bohannon Show” with guests, Dr. Andreas Kogelnik, Ryan Prior and Llewellyn King
References[edit | edit source]
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "The Clinic". Open Medicine Institute. Retrieved April 17, 2019.
- ↑ "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019.
- ↑ Kogelnik, AM; Loomis, K; Hoegh-Petersen, M; Rosso, F; Hischier, C; Montoya, JG. "Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue". Journal of Clinical Virology. 37: Suppl 1:S33-8. doi:10.1016/S1386-6532(06)70009-9. PMID 17276366.
- ↑ Knox, K.; Carrigan, D.; Simmons, G.; Teque, F.; Zhou, Y.; Hackett, J.; Qiu, X.; Luk, K.-C.; Schochetman, G.; Kogelnik, AM (July 1, 2011). "No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected". Science. 333 (6038): 94–97. doi:10.1126/science.1204963. ISSN 0036-8075.
- ↑ Montoya, JG; Kogelnik, AM; Bhangoo, M; Lunn, MR; Flamand, L; Merrihew, LE; Watt, T; Kubo, JT; Paik, J; Desai, M (2013), "Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.", Journal of Medical Virology, 85 (12): 2101-9, doi:10.1002/jmv.23713, PMID 23959519
- ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- ↑ "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.
- ↑ "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.
- ↑ "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.